VDR |
VDR, NR1I1: Vitamin D3 receptor |
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
31.770 |
Evidence |
|
JUNB |
JUNB: Transcription factor jun-B |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
31.770 |
Evidence |
O
|
PPP1R12A |
PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
31.770 |
Evidence |
|
JUNB |
JUNB: Transcription factor jun-B |
RELA |
RELA, NFKB3: Transcription factor p65 |
31.770 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
VDR |
VDR, NR1I1: Vitamin D3 receptor |
31.770 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
31.770 |
Evidence |
O
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
CD36 |
CD36, GP3B, GP4: Platelet glycoprotein 4 |
31.770 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
31.770 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
31.650 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
31.650 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
31.650 |
Evidence |
|
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
PTGES3 |
PTGES3, P23, TEBP: Prostaglandin E synthase 3 |
31.650 |
Evidence |
|
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
JAK1 |
|
31.640 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HFE |
HFE, HLAH: Hereditary hemochromatosis protein precursor |
31.610 |
Evidence |
|
TLR9 |
TLR9, UNQ5798/PRO19605: Toll-like receptor 9 precursor |
TLR5 |
IPI00656104 |
31.610 |
Evidence |
|
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
31.610 |
Evidence |
|
CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
31.610 |
Evidence |
|
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
BCL2L2 |
BCL2L2, BCLW, KIAA0271: Apoptosis regulator Bcl-W |
31.610 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HFE |
HFE, HLAH: Hereditary hemochromatosis protein precursor |
31.610 |
Evidence |
|
BID |
BID: BH3-interacting domain death agonist |
BIK |
BIK, NBK: Bcl-2-interacting killer |
31.610 |
Evidence |
|
STX6 |
STX6: Syntaxin-6 |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
31.610 |
Evidence |
|
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
31.610 |
Evidence |
|
LYL1 |
LYL1: Protein lyl-1 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
31.610 |
Evidence |
|
BID |
BID: BH3-interacting domain death agonist |
BAK1 |
IPI00003352 |
31.610 |
Evidence |
|
STX6 |
STX6: Syntaxin-6 |
SYBL1 |
SYBL1: Synaptobrevin-like protein 1 |
31.610 |
Evidence |
|